A Dorchester hospital is stepping up its support for prostate cancer charities after welcoming the town's mayor for a visit. The mayor and mayoress of Dorchester, Cllr Les Fry and Julie Fry, visited The Winterbourne Hospital to discuss plans to…
TOPEKA, Kan. (KSNT) — As concerns grow over the uninsured rate for Kansas children, health professionals, activists and members of the public gathered for an educational forum to learn more about how to fix the issue. The Kansas Health Institute (KHI)…
Dr. Moon noted that the biological rationale for incorporating PSMA PET into this setting is that PSMA is overexpressed in most prostate cancer cells, providing a target for molecular imaging with 68Ga-PSMA-11. Importantly, increasing PSMA expression and PSMA PET uptake…
At EAU 2026, Dr. Buteau and colleagues aimed to demonstrate that 68Ga-PSMA-11 PET/CT could reduce patients requiring biopsy and limit biopsy to targeted cores, without significantly decreasing significant prostate cancer diagnosis. Significant prostate cancer was defined as Gleason score 3+4 (≥10% pattern…
Will PSMA PET ever replace prostate biopsy? Before an irreversible treatment, clinicians need more information than a binary determination of whether clinically significant prostate cancer is present. A tissue diagnosis provides answers regarding: False positive results of PSMA PET imaging…
Alberto Briganti and Yao Zhu debate whether PSMA PET can replace prostate biopsy. Dr. Briganti argues biopsy remains necessary even with positive PSMA findings, since imaging cannot capture tumor volume, grading heterogeneity, variant histology, or transcriptomic signatures, and warns that…
Looking to schedule an appointment? We now provide you with 24/7 electronic access to view your medical records, pay your bill and exchange secure messages with our staff. Medical Office Building North2326 18th Street, Ste. 230Columbus, IN 47201 Monday - Friday8am - 4:30pm Columbus Regional Health Urology specializes in…
Her journey has included ten recurrences, ongoing surveillance and treatment, chronic pain, mobility challenges and the financial burden of cancer care. It has also led her to build a community where other patients can find the information, understanding and support…
Di Zhao presents preclinical work on B7-H3, an overexpressed immune checkpoint molecule in prostate cancer that rises with disease progression and is associated with worse outcomes. Using the antibody-drug conjugate DS-7300a, now in phase 3 trials, Dr. Zhao found p53 loss confers resistance…
Heterogeneity across studies was assessed using I² and τ² statistics, and the pooled estimate showed moderate heterogeneity, with a Q statistic of 19.95 and I² of 34.8 percent. Publication bias was evaluated using a funnel plot, a contour-enhanced funnel plot, and Egger’s regression test. Egger’s…
BPH, prostatitis, PSA screening, and urinary/sexual function concerns.
An article joins this feed when it matches these terms. Each one is also a search of its own.